297 related articles for article (PubMed ID: 22132887)
1. Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.
Kim BR; Yang EK; Kim DY; Kim SH; Moon DC; Lee JH; Kim HJ; Lee JC
Clin Exp Immunol; 2012 Jan; 167(1):73-83. PubMed ID: 22132887
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma.
Kim BR; Yang EK; Kim SH; Moon DC; Kim HJ; Lee JC; Kim DY
J Microbiol; 2011 Feb; 49(1):115-20. PubMed ID: 21369988
[TBL] [Abstract][Full Text] [Related]
3. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma.
Lee JS; Kim JW; Choi CH; Lee WK; Chung HY; Lee JC
J Microbiol; 2008 Apr; 46(2):221-7. PubMed ID: 18545973
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.
Kim HL; Sun X; Subjeck JR; Wang XY
Cancer Immunol Immunother; 2007 Jul; 56(7):1097-105. PubMed ID: 17146628
[TBL] [Abstract][Full Text] [Related]
6. Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells.
Bleumer I; Tiemessen DM; Oosterwijk-Wakka JC; Völler MC; De Weijer K; Mulders PF; Oosterwijk E
J Immunother; 2007 Jan; 30(1):116-22. PubMed ID: 17198090
[TBL] [Abstract][Full Text] [Related]
7. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM
Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145
[TBL] [Abstract][Full Text] [Related]
8. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
9. Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma.
Shimizu K; Uemura H; Yoshikawa M; Yoshida K; Hirao Y; Iwashima K; Saga S; Yoshikawa K
Oncol Rep; 2003; 10(5):1307-11. PubMed ID: 12883698
[TBL] [Abstract][Full Text] [Related]
10. Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection.
Herbert N; Haferkamp A; Schmitz-Winnenthal HF; Zöller M
J Immunol; 2010 Jul; 185(2):902-16. PubMed ID: 20548033
[TBL] [Abstract][Full Text] [Related]
11. DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma.
Ma H; Tan Y; Wen D; Qu N; Kong Q; Li K; Ma S; Zhang J
Hum Vaccin Immunother; 2021 Nov; 17(11):4363-4373. PubMed ID: 34851805
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
Birkhäuser FD; Koya RC; Neufeld C; Rampersaud EN; Lu X; Micewicz ED; Chodon T; Atefi M; Kroeger N; Chandramouli GV; Li G; Said JW; McBride WH; Kabbinavar FF; Ribas A; Pantuck AJ; Belldegrun AS; Riss J
J Immunother; 2013 Feb; 36(2):102-11. PubMed ID: 23377663
[TBL] [Abstract][Full Text] [Related]
13. Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.
Mukouyama H; Janzen NK; Hernandez JM; Lam JS; Caliliw R; Wang AY; Figlin RA; Belldegrun AS; Zeng G
Clin Cancer Res; 2004 Feb; 10(4):1421-9. PubMed ID: 14977845
[TBL] [Abstract][Full Text] [Related]
14. Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.
Fu Q; Wu Y; Yan F; Wang N; Wang W; Cao X; Wang Y; Wan T
Cell Mol Immunol; 2011 Sep; 8(5):424-32. PubMed ID: 21785448
[TBL] [Abstract][Full Text] [Related]
15. Covalent crosslinking of tumor antigens stimulates an antitumor immune response.
Wang Y; Wang XY; Subjeck JR; Kim HL
Vaccine; 2010 Sep; 28(40):6613-20. PubMed ID: 20682362
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
[TBL] [Abstract][Full Text] [Related]
17. Acinetobacter baumannii outer membrane protein A induces dendritic cell death through mitochondrial targeting.
Lee JS; Choi CH; Kim JW; Lee JC
J Microbiol; 2010 Jun; 48(3):387-92. PubMed ID: 20571958
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC; Tiemessen DM; Bleumer I; de Vries IJ; Jongmans W; Adema GJ; Debruyne FM; de Mulder PH; Oosterwijk E; Mulders PF
J Immunother; 2002; 25(6):500-8. PubMed ID: 12439347
[TBL] [Abstract][Full Text] [Related]
20. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
